The economic burden of global blindness: a price too high! The World Health Organisation defines blindness as a best corrected visual acuity of less than 3/60.1 Using this definition it is estimated that there are currently 37 9 million blind people (1-4 million children 0-15 years of age, and 36-5 million adults 15 years of age or greater) worldwide.2 Of this figure roughly 75% of all blind people live in the developing countries of Asia (21-4 million) and Africa (7.1 million), typically in rural areas with few or drastically underused eye care facilities.2 3 fThis column is obtained by multiplying column (e) by 0-75 the total cost of adult blindness and by 0-5 the total cost of childhood blindness.
The economic burden ofglobal blindness: a price too high! Advances in data collection, organisation, and distribution have made it possible to significantly reduce duplication of services and to reallocate resources to areas or specific activities where these may be of the greatest economic and social benefit.
In a parallel fashion, sequencing allocation and routing algorithms, queuing models and decision analyses have been developed to a high standard in recent years by operations researchers. 7 The results of their work are now being applied to significant competitive advantage by the management of firms, both large and (with the ever increasing use of personal computers), small worldwide. 'Just in time inventory' (IT-I) delivery systems, now common, have resulted in huge cost savings and higher per unit profits for many retail and manufacturing firms in recent years.8 This is one simple example of the practical application of operations research techniques in the commercial world.
If the private sector can, so rapidly, take advantage of the fruits of this research why can't the public and 'parapublic' sectors follow its lead? No doubt they can! Moreover, if the direct and indirect costs of global blindness are to be significantly reduced, they must! It is feasible today that a system similar to the JIT-I models of the commercial world could be developed so as to better allocate scarce ophthalmic resources to those areas where these might meet the greatest need at the lowest per unit cost in the most effective way possible. This presents a tremendous challenge. But tools to do the job are at hand. These simply need to be applied. 
